Anjanish R. Gondalia
“The inception of Kalintis was unbelievable. I went to visit an empty plot of land with a rundown intermediate plant on a hot summer day and shook hands to acquire the unit in less than 10 minutes after walking around.” From that day forward Anjanish was involved in every aspects of Kalintis Healthcare and its future. Hard work & dedication transformed the intermediate plant into a US-FDA approved facility actively manufacturing API’s, Intermediates & Complex Custom Molecules for USA, EU & ROW. “It was a massive team effort and we all had one goal.”
Anjanish started his career at Corepharma LLC., strategically identifying and targeting ANDA’s with competitive market value and successful sales platforms. Later, he went to join Apicore, where he became involved in sourcing partners for Apicore’s DMF portfolio. The work contributed to several successful relationships, including one first-to-file (P-IV) with a major generic partner. Both experiences were instrumental in his next role as V.P Operations at Leading Pharma LLC. With a highly skilled team Anjanish oversaw the growth of Leading Pharma from a 10,000 (Sq. Ft.) operation with 35 employees, annual capacity of 300 Million tablets to an 80,000 (Sq. Ft.) operation with 180 employees, annual capacity of 2 Billion tablets. “I am still active & it’s the best job I’ve ever had.”
He is also on the Board of Directors at NJ Biopharmaceuticals, CRO/CDMO focused on providing expertise in chemistry and biological services to partners in the biotech & pharmaceutical sectors.
“Pharma is unique because everyone involved has figured out a way to convert difficulty & challenges into excitement and opportunity.”
Biology - Rutgers
MBA – Strayer